Effective Treatment for Combined Amlodipine and Metformin Overdose

Effective Treatment for Combined Amlodipine and Metformin Overdose

The combined toxicity of amlodipine and metformin is a rarely reported phenomenon in the literature. The management varies depending on the clinical status of the patient. We present a case that was managed successfully... read more

EKG/ECG Interpretation Made Easy

EKG/ECG Interpretation Made Easy

In this guide, you will understand how ECGs are performed, what they represent about the heart, and what it means to see something you don't think is normal. Before you get into the hard stuff—the actual interpretation... read more

Bempedoic Acid Associated with Lower Risk of Cardiovascular Events

Bempedoic Acid Associated with Lower Risk of Cardiovascular Events

Among statin-intolerant patients, treatment with bempedoic acid was associated with a lower risk of major adverse cardiovascular events (death from cardiovascular causes, nonfatal myocardial infarction, nonfatal stroke, or... read more

Adult Sepsis Hospitalization and Risk of Subsequent Cardiovascular Events

Adult Sepsis Hospitalization and Risk of Subsequent Cardiovascular Events

Adult sepsis survivors experience an increased hazard of major cardiovascular events compared to survivors of a non-sepsis hospitalization. 254,241 adult sepsis survivors were matched to adult survivors of non-sepsis hospitalization... read more

COVID-19 and Myocardial Infarction

COVID-19 and Myocardial Infarction

COVID-19 is a risk factor for myocardial infarction and stroke through self-controlled case series evaluation, a method that has been used to establish the risk of myocardial infarction associated with influenza infection. Regarding... read more

Single Troponin Testing in ED Patients With Suspected Acute Myocardial Infarction

Single Troponin Testing in ED Patients With Suspected Acute Myocardial Infarction

One of the most common reasons for Emergency Department (ED) visits is chest pain. While most of these presentations are at a low risk for cardiac events, it is generally required to perform a full work-up to rule out an... read more

Management of Cardiogenic Shock

Management of Cardiogenic Shock

Cardiogenic shock (CS) remains the most common cause of death in patients with acute myocardial infarction although mortality could be reduced from formerly ∼80% to 40–50%. In addition to percutaneous coronary intervention... read more

Multipotent Fetal-derived Cdx2 Cells From Placenta Regenerate the Heart

Multipotent Fetal-derived Cdx2 Cells From Placenta Regenerate the Heart

Researchers at the Icahn School of Medicine at Mount Sinai have demonstrated that stem cells derived from the placenta known as Cdx2 cells can regenerate healthy heart cells after heart attacks in animal models. The extremely... read more

Peer Support in Critical Care

Peer Support in Critical Care

Peer support appeared to reduce psychologic morbidity and increase social support. The evidence for peer support in critically ill populations is limited. There is a need for well-designed and rigorously reported research... read more

Rivaroxaban Lowers Cardiovascular Risk But Increases Bleeding Risk

Rivaroxaban Lowers Cardiovascular Risk But Increases Bleeding Risk

In 27,395 patients with stable atherosclerotic disease, the addition of 2.5 mg rivaroxaban twice daily to aspirin therapy reduced the rates of cardiovascular death, stroke, or nonfatal MI, at the cost of increased major bleeding... read more

Understanding How to Improve Quality and Value for Patients With AMI

Understanding How to Improve Quality and Value for Patients With AMI

Although the United States lags behind comparable nations in many health measures, mortality following acute myocardial infarction (AMI) is lower in the United States than in many other developed countries, including Finland,... read more

Association of the Hospital Readmissions Reduction Program Implementation With Readmission and Mortality Outcomes in Heart Failure

Association of the Hospital Readmissions Reduction Program Implementation With Readmission and Mortality Outcomes in Heart Failure

Among fee-for-service Medicare beneficiaries discharged after heart failure hospitalizations, implementation of the HRRP was temporally associated with a reduction in 30-day and 1-year readmissions but an increase in 30-day... read more

Oxygen Therapy in Suspected Acute Myocardial Infarction

Oxygen Therapy in Suspected Acute Myocardial Infarction

Routine use of supplemental oxygen in patients with suspected myocardial infarction who did not have hypoxemia was not found to reduce 1-year all-cause mortality. A total of 6629 patients were enrolled. The median duration... read more

Accuracy of Medical Claims for Identifying Cardiovascular and Bleeding Events After Myocardial Infarction

Accuracy of Medical Claims for Identifying Cardiovascular and Bleeding Events After Myocardial Infarction

In this secondary analysis of a clinical trial of 12 365 patients with acute myocardial infarction, the cumulative 1-year event rates for myocardial infarction, stroke, and bleeding were lower when medical claims were used... read more